Havrix
Hepatitis A Vaccine · Injection, Suspension · Intramuscular
No FDA structured label text is available for Havrix. The NDC listings below come from the FDA National Drug Code directory.
Active ingredients
Havrix NDC products (4)
| NDC | Strength & form | Labeler | Type |
|---|---|---|---|
| 50090-1502 | Hepatitis A Virus Strain Hm175 Antigen (formaldehyde Inactivated) 1440 [iU]/mL Injection, Suspension | A-S Medication Solutions | BLA |
| 50090-3781 | Hepatitis A Virus Strain Hm175 Antigen (formaldehyde Inactivated) 720 [iU]/.5mL Injection, Suspension | A-S Medication Solutions | BLA |
| 58160-825 | Hepatitis A Virus Strain Hm175 Antigen (formaldehyde Inactivated) 720 [iU]/.5mL Injection, Suspension | GlaxoSmithKline Biologicals SA | BLA |
| 58160-826 | Hepatitis A Virus Strain Hm175 Antigen (formaldehyde Inactivated) 1440 [iU]/mL Injection, Suspension | GlaxoSmithKline Biologicals SA | BLA |
Frequently asked questions
Who makes Havrix?
Havrix is listed by 2 labelers in the FDA NDC directory, including A-S Medication Solutions, GlaxoSmithKline Biologicals SA.